Risk-adapted Therapy for Adult Acute Myeloid Leukemia.

NCT01716793 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

354

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myelocytic, Acute

Interventions

DRUG: Ara-C
OTHER: Autologous transplantation
OTHER: Allogeneic HLA-identical sibling transplantation
OTHER: CD34+ selection

Sponsor

Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias